Founder and CEO, Insilico Medicine
Appears in 1 story
Leading the company through rentosertib Phase III and the MMAI Gym rollout
Insilico Medicine released AI models Sept. 2 that it says outperform the dedicated software drug companies have used for years. The language-model specialists cover chemical synthesis, drug-safety prediction, and target-binding strength.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
